Impact of routine C-peptide screening in individuals with a clinician diagnosis of type 1 diabetes

被引：0
|
作者：
Foteinopoulou, E. [1 ]
Clarke, C. [1 ]
Pattenden, R. [1 ]
McKnight, J. [1 ]
Strachan, M. W. J. [1 ]
机构：
[1] Western Gen Hosp, Edinburgh, Midlothian, Scotland
来源：
DIABETOLOGIA | 2018年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
302
引用
收藏
页码：S152 / S153
页数：2
相关论文
共 50 条
  • [1] Improve diagnostic accuracy following routine C-peptide testing in individuals with a clinician diagnosis of Type 1 diabetes
    Foteinopoulou, E.
    Clarke, C.
    Pattenden, R.
    McKnight, J.
    Strachan, M. W. J.
    SCOTTISH MEDICAL JOURNAL, 2019, 64 (04) : NP65 - NP66
  • [2] Impact of routine clinic measurement of serum C-peptide in people with a clinician-diagnosis of type 1 diabetes
    Foteinopoulou, Evgenia
    Clarke, Catriona A. L.
    Pattenden, Rebecca J.
    Ritchie, Stuart A.
    McMurray, Emily M.
    Reynolds, Rebecca M.
    Arunagirinathan, Ganesan
    Gibb, Fraser W.
    McKnight, John A.
    Strachan, Mark W. J.
    DIABETIC MEDICINE, 2021, 38 (07)
  • [3] Comment on 'impact of routine Clinic Measurement of random Serum c-peptide in people with a Clinician Diagnosis of type 1 diabetes'
    Patel, Shivani K.
    Fourlanos, Spiros
    Greenfield, Jerry R.
    DIABETIC MEDICINE, 2021, 38 (04)
  • [4] Genetics of C-Peptide and Age at Diagnosis in Type 1 Diabetes
    Roshandel, Delnaz
    Spiliopoulou, Athina
    Mcgurnaghan, Stuart J.
    Iakovliev, Andrii
    Lipschutz, Debby
    Hayward, Caroline
    Bull, Shelley B.
    Klein, Barbara E. K.
    Lee, Kristine E.
    Kinney, Gregory L.
    Rewers, Marian
    Costacou, Tina
    Miller, Rachel G.
    Mckeigue, Paul M.
    Paterson, Andrew D.
    Colhoun, Helen M.
    DIABETES, 2025, 74 (02)
  • [5] Response to comment on 'impact of routine clinic measurement of random serum C-peptide in people with a clinician diagnosis of type 1 diabetes' doi: 10.1111/dme.14449
    Foteinopoulou, Evgenia
    Strachan, Mark W. J.
    DIABETIC MEDICINE, 2022, 39 (01)
  • [6] The impact of age, body mass index, and pubertal stage on C-peptide at type 1 diabetes diagnosis
    Cimbek, Emine Ayca
    Beyhun, Nazim Ercument
    Karaguzel, Gulay
    HORMONE RESEARCH IN PAEDIATRICS, 2022, 95 (SUPPL 2): : 88 - 88
  • [7] Association of a Type 1 Diabetes Genetic Risk Score with C-Peptide and Age of Diagnosis in Type 1 Diabetes
    Roshandel, Delnaz
    Oram, Richard A.
    Hattersley, Andrew T.
    Weedon, Michael N.
    Gubitosi-Klug, Rose
    Bull, Shelley B.
    Paterson, Andrew D.
    DIABETES, 2016, 65 : A458 - A458
  • [8] Factors associated with preservation of C-peptide levels at the diagnosis of type 1 diabetes
    Szypowska, Agnieszka
    Groele, Lidia
    Wysocka-Mincewicz, Marta
    Mazur, Artur
    Lisowicz, Lucyna
    Ben-Skowronek, Iwona
    Sieniawska, Joanna
    Klonowska, Bozenna
    Charemska, Dorota
    Nawrotek, Jolanta
    Jalowiec, Irena
    Bossowski, Artur
    Noiszewska, Klaudyna
    Pyrzak, Beata
    Rogozinska, Izabela
    Szalecki, Mieczyslaw
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2018, 32 (06) : 570 - 574
  • [9] Metabolic impact of residual C-peptide secretion in type 1 diabetes mellitus
    Lopes, Valentim
    Sousa, Maria Eduarda
    Lopes, Sara Campos
    Lages, Adriana De Sousa
    ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2024, 68
  • [10] Persistence of C-peptide secretion and impact on health in advanced type 1 diabetes
    Faustman, D. L.
    Wang, L.
    Leung, S.
    DIABETOLOGIA, 2012, 55 : S195 - S195
12345